UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Omics and Multi-Omics in IBD: No Integration, No Breakthroughs

International journal of molecular sciences, 2023-10, Vol.24 (19), p.14912

Fiocchi, Claudio

2023

Volltextzugriff (PDF)

Immunopathogenesis of IBD: current state of the art

Nature reviews. Gastroenterology & hepatology, 2016-01, Vol.13 (1), p.13-27

2016

Volltextzugriff (PDF)

Inflammatory Bowel Disease: Complexity and Variability Need Integration

Frontiers in medicine, 2018-03, Vol.5, p.75-75

Fiocchi, Claudio

2018

Volltextzugriff (PDF)

Intestinal fibrosis in IBD-a dynamic, multifactorial process

Nature reviews. Gastroenterology & hepatology, 2009-04, Vol.6 (4), p.228-235

2009

Volltextzugriff (PDF)

Etiopathogenesis of inflammatory bowel diseases

World journal of gastroenterology : WJG, 2006-08, Vol.12 (30), p.4807

2006

Volltextzugriff (PDF)

Etiopathogenesis of inflammatory bowel diseases

World journal of gastroenterology : WJG, 2006-08, Vol.12 (30), p.4807

2006

Volltextzugriff (PDF)

Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease

American journal of physiology: Gastrointestinal and liver physiology, 2012-10, Vol.303 (7), p.G786-G801

2012

Volltextzugriff (PDF)

Inflammatory bowel disease: Etiology and pathogenesis

Gastroenterology (New York, N.Y. 1943), 1998-07, Vol.115 (1), p.182-205

Fiocchi, Claudio

1998

Volltextzugriff (PDF)

Inflammatory Bowel Disease Therapy: Beyond the Immunome

Frontiers in immunology, 2022-05, Vol.13, p.864762-864762

2022

Volltextzugriff (PDF)

A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

PLoS biology, 2020-11, Vol.18 (11), p.e3000970

2020

Volltextzugriff (PDF)

Drug development in IBD: from novel target identification to early clinical trials

Gut, 2016-08, Vol.65 (8), p.1233-1239

2016

Volltextzugriff (PDF)

VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease

The Journal of clinical investigation, 2014-09, Vol.124 (9), p.3863-3878

2014

Volltextzugriff (PDF)

Themes in fibrosis and gastrointestinal inflammation

American journal of physiology: Gastrointestinal and liver physiology, 2011-05, Vol.300 (5), p.G677-G683

2011

Volltextzugriff (PDF)

Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

Proceedings of the National Academy of Sciences - PNAS, 2010-04, Vol.107 (17), p.8017-8022

2010

Volltextzugriff (PDF)

Intestinal fibrosis in inflammatory bowel disease - Current knowledge and future perspectives

Journal of Crohn's and colitis, 2008-12, Vol.2 (4), p.279-290

2008

Volltextzugriff (PDF)

The Postbiotic Butyrate Mitigates Gut Mucosal Disruption Caused by Acute Ethanol Exposure

International journal of molecular sciences, 2024-02, Vol.25 (3), p.1665

2024

Volltextzugriff (PDF)

Inflammatory bowel disease: the role of environmental factors

Autoimmunity Reviews, 2004-07, Vol.3 (5), p.394-400

2004

Volltextzugriff (PDF)

Current Therapy in Inflammatory Bowel Disease: Why and How We Need to Change?

European medical journal. Innovations, 2022-01, p.40-49

2022

Volltextzugriff (PDF)

Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases

Gastroenterology (New York, N.Y. 1943), 2017-02, Vol.152 (2), p.340-350.e6

2017

Volltextzugriff (PDF)

IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis

Gut, 2014-11, Vol.63 (11), p.1728-1736

2014

Volltextzugriff (PDF)

Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease

Current opinion in gastroenterology, 2013-11, Vol.29 (6), p.608-613

2013

Volltextzugriff (PDF)

What’s new in IBD therapy: An “omics network” approach

Pharmacological research, 2020-09, Vol.159, p.104886-104886, Article 104886

2020

Volltextzugriff (PDF)

Ulcerative Colitis

The New England journal of medicine, 2011-11, Vol.365 (18), p.1713-1725

2011

Volltextzugriff (PDF)

Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?

Clinical & developmental immunology, 2004-01, Vol.11 (3-4), p.195-204

2004

Volltextzugriff (PDF)

Corticotropin-Releasing Hormone Family of Peptides Regulates Intestinal Angiogenesis

Gastroenterology (New York, N.Y. 1943), 2010-06, Vol.138 (7), p.2457-2467.e5

2010

Volltextzugriff (PDF)

1 – 25 von 355

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Journals Frontfile Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(341)
Mit Volltextzugriff
(325)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(167)
Life Sciences & Biomedicine
(164)
Humans
(140)
Gastroenterology & Hepatology
(102)
Inflammatory Bowel Disease
(70)
Gastroenterology And Hepatology
(56)
Biological And Medical Sciences
(54)
Animals
(46)
Male
(44)
Medical Sciences
(44)
Female
(38)
Ulcerative Colitis
(37)
Gastroenterology. Liver. Pancreas. Abdomen
(36)
Crohn's Disease
(33)
Intestinal Mucosa - Immunology
(32)
Other Diseases. Semiology
(32)
Adult
(29)
Inflammatory Bowel Diseases - Immunology
(28)
Middle Aged
(28)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(28)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Omics and Multi-Omics in IBD: No Integration, No Breakthroughs

Immunopathogenesis of IBD: current state of the art

Inflammatory Bowel Disease: Complexity and Variability Need Integration

Intestinal fibrosis in IBD-a dynamic, multifactorial process

Etiopathogenesis of inflammatory bowel diseases

Etiopathogenesis of inflammatory bowel diseases

Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease

Inflammatory bowel disease: Etiology and pathogenesis

Inflammatory Bowel Disease Therapy: Beyond the Immunome

A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

Drug development in IBD: from novel target identification to early clinical trials

VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease

Themes in fibrosis and gastrointestinal inflammation

Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

Intestinal fibrosis in inflammatory bowel disease - Current knowledge and future perspectives

The Postbiotic Butyrate Mitigates Gut Mucosal Disruption Caused by Acute Ethanol Exposure

Inflammatory bowel disease: the role of environmental factors

Current Therapy in Inflammatory Bowel Disease: Why and How We Need to Change?

Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases

IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis

Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease

What’s new in IBD therapy: An “omics network” approach

Ulcerative Colitis

Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?

Corticotropin-Releasing Hormone Family of Peptides Regulates Intestinal Angiogenesis

Aktive Filter

Suchergebnisse filtern